Australian Clinical Labs【ACL】銘柄情報

Australian Clinical Labs Limited (ACL) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.24

( 0.45% )

買値

2.22

売値

2.24

出来高

295,951

2.23 日の範囲 2.27

1.8325 52 週間の範囲 2.97

時価総額

415.568M

前日終値

2.23

始値

2.27

時刻

117

2.24

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

AUD 641,351

発行済株式数

185,521,550

配当利回り

0.13 (5.58%)

PER

15.89

1 株当たり利益 (EPS)

0.14

歳入

737.49M

純利益

26.31M

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematol... Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs. It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

www.clinicallabs.com.au

本社

Clayton, Australia

設立

2026

Australian Clinical Labs Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker ACL. The last closing price for Australian Clinical Labs was AUD2.23. Over the last year, Australian Clinical Labs shares have traded in a share price range of AUD 1.8325 to AUD 2.97.

Australian Clinical Labs currently has 185,521,550 shares in issue. The market capitalisation of Australian Clinical Labs is AUD415.57 million. Australian Clinical Labs has a price to earnings ratio (PE ratio) of 15.89.

Alchemia Limited slammed 53%: Is the stock a buy?

http://www.fool.com.au/2015/05/29/alchemia-limited-slammed-53-is-the-stock-a-buy/

Alchemia Announces Initiation of Phase II Trial in Small Cell Lung Cancer

Alchemia Limited (ASX:ACL), today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug...

UPDATE: Dr Reddy's Gets US OK For Generic Anticlotting Injection

Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received U.S. regulatory approval to launch a copy of GlaxoSmithKline PLC's (GSK...

Dr. Reddy’s Announces the USFDA Approval of Fondaparinux Sodium Injection

Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has...

Dr Reddy's Gets US OK To Sell Generic Injection To Prevent Blood Clots

Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received final approval from the U.S. Food and Drug Administration to sell a...

Alchemia to Present at Cowen and Company 31st Annual Health Care Conference

Alchemia Limited (ASX: ACL) announced today that Pete Smith, Chief Executive Officer, is scheduled to present a corporate update...

Alchemia and Dr Reddy’s Expand Fondaparinux Marketing Collaboration

Alchemia (ASX:ACL) today announced the agreement of terms with Dr Reddy’s Limited for marketing fondaparinux sodium for injection...

Alchemia’s HyACT Technology Enhances the Killing of Cancer Stem Cell Populations in Breast and Colorectal Cancer

Alchemia’s (ASX: ACL) subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research...

Emisphere Technologies and Alchemia to Research an Oral Formulation of Fondaparinux with Eligen® Technology

Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) today announced that they are joining efforts to develop an...

CORRECT: Alcon 3Q Profit Down 18%, Raises 2009 Earnings View

("Alcon 3Q Profit Down 18%, Raises 2009 Earnings View 2nd Time," published at 6:12 p.m. EDT, incorrectly included a tax benefit for the latest...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.09	4.18604651163	2.15	2.32	2.14	504101	2.23273922	DE
4	0.21	10.3448275862	2.03	2.32	1.99	444773	2.18412519	DE
12	0.15	7.17703349282	2.09	2.32	1.8325	621977	2.01904256	DE
26	-0.47	-17.3431734317	2.71	2.86	1.8325	687640	2.18087524	DE
52	-0.57	-20.2846975089	2.81	2.97	1.8325	735110	2.44429693	DE
156	-1.21	-35.0724637681	3.45	3.855	1.8325	709158	2.79037856	DE
260	-1.25	-35.8166189112	3.49	6.39	1.8325	721998	3.34632323	DE